BIOTECHNOLOGY VALUE FUND L P

Holdings History for Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)

Symbol: GPCR on Nasdaq
Investment type: Equity / Ordinary Shares, par value $0.0001 per share
Latest Disclosed Shares Owned: 10,437,066 shares
Security Ownership %: 4.9%

BVF PARTNERS L P/IL ownership in Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR)

17 Feb 2026 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10,437,066 shares of Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR). This represents 4.9% ownership of the company. In their previous filing dated 18 Aug 2025, BIOTECHNOLOGY VALUE FUND L P had reported owning 9,611,751 shares, indicating an increase of +8.6%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BVF PARTNERS L P/IL	4.9%	-12%	$723,914,898	10,437,066	+825,315	+8.6%	$69.36	13G/A	31 Dec 2025	17 Feb 2026, 16:18
BVF PARTNERS L P/IL	5.6%		$171,089,168	9,611,751			$17.80	13G	11 Aug 2025	18 Aug 2025, 17:02